Verition Fund Management LLC Makes New Investment in Solventum Co. (NYSE:SOLV)

Verition Fund Management LLC acquired a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 15,868 shares of the company's stock, valued at approximately $1,106,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SOLV. Copeland Capital Management LLC purchased a new stake in Solventum during the third quarter valued at $26,000. Mather Group LLC. purchased a new stake in shares of Solventum during the 3rd quarter valued at about $27,000. Hollencrest Capital Management bought a new position in shares of Solventum in the 2nd quarter valued at about $25,000. Deseret Mutual Benefit Administrators purchased a new position in Solventum in the second quarter worth about $25,000. Finally, Richard W. Paul & Associates LLC bought a new stake in Solventum during the second quarter worth approximately $26,000.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on SOLV. Stifel Nicolaus began coverage on Solventum in a research note on Tuesday, October 8th. They issued a "buy" rating and a $82.00 price objective for the company. Morgan Stanley lifted their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research note on Monday, November 11th. Piper Sandler raised their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a "neutral" rating in a report on Friday, November 8th. The Goldman Sachs Group increased their price objective on shares of Solventum from $48.00 to $54.00 and gave the stock a "sell" rating in a research report on Monday, August 12th. Finally, Mizuho began coverage on Solventum in a research note on Wednesday. They issued a "neutral" rating and a $70.00 target price on the stock. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company. According to MarketBeat, Solventum has a consensus rating of "Hold" and a consensus price target of $68.29.

Solventum Stock Up 0.6 %

NYSE:SOLV traded up $0.39 during mid-day trading on Friday, reaching $69.96. The company's stock had a trading volume of 1,049,486 shares, compared to its average volume of 1,002,431. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05. The stock has a fifty day moving average of $70.69 and a 200-day moving average of $62.89.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.